![](https://iperfusion.org/wp-content/uploads/2023/12/IMG_0240.jpeg)
Investigating the Complications and Causes of Failure of the AngioVac System: A Post-Marketing Surveillance From the MAUDE Database
The AngioVac aspiration thrombectomy device, approved for removing thrombi during bypass, has been reported to commonly fail due to physical damage and is associated with adverse events such as pulmonary embolism and vessel perforation, as per data from the Manufacturer and User Facility Device Experience database between April 2013 and March 2022. Physicians should be cognizant of these potential complications and the fact that the device’s most frequent failures are attributed to its physical damage.